Inhaled Niclosamide a Potential Effective Antiviral to Treat COVID-19

An infrared image of nasal spray being administered.
September 29, 2020
Researchers in the lab of Dr. Hugh D.C. Smyth have released promising results of a new method to treat SARS-CoV-2, the coronavirus that causes COVID-19. The antiviral niclosamide, when incorporated with human lysozyme as a carrier molecule, shows potential as an effective COVID-19 treatment when delivered directly to the airways.

New Thin Film Technology to Revolutionize Storage and Distribution of Biologic Treatments and Vaccines

A hand touching a transparent sheet.
September 29, 2020
The newly-formed Jurata Thin Film will work to bring Dr. Maria Croyle's thin film technology to market, allowing biologics and vaccines to be packaged, shipped, and stored at room temperature for extended periods of time.

Live Subject Testing Shows Promising Delivery Method for COVID-19 Antiviral Treatment

A microscopic image.
September 23, 2020
Live subject testing results from the Williams Lab show that dry powder inhalation could be a potent and effective delivery method of the antiviral remdesivir to treat patients affected by COVID-19.

Mukhopadhyay Wins Research Excellence Award

A man standing in a research laboratory.
September 10, 2020
Associate Professor Somshuvra Mukhopadhyay, M.B.B.S., Ph.D. wins the 2020 Co-op Research Excellence Award for Best Paper. The awards are presented each year by the Office of the Vice President for Research and the University Co-operative Society.

Richburg Receives NIH Grant Award for Toxicant Injury Research

A man smiling
August 10, 2020
Associate Dean for Research and Graduate Studies John H. Richburg, Ph.D. received notice from the National Institutes of Health (NIH) awarding him a research grant for a five-year term. The NIH’s grant award for Dr. Richburg’s research totals $2,694,316.

Dry Powder Inhalation Could Be a Potent Tool in COVID-19 Antiviral Treatment

dry powder inhaler
July 28, 2020
Researchers in the Division of Molecular Pharmaceutics and Drug Delivery, led by Robert O. (Bill) Williams III, plan to use their novel thin-film-freezing technology to deliver remdesivir through dry powder inhalation, potentially making COVID-19 antiviral treatment more potent, easier to administer, and more broadly available.

UT 3D Printing Labs Enter Patent License Agreement to Develop Digital 3D Drug Manufacturing and Advanced Drug Delivery Systems

Patient-centric 3D printing paradigm of medicines at the point-of-care.
July 17, 2020
Assistant Professor Mo Maniruzzaman’s Pharmaceutical Engineering and 3D Printing (PharmE3D) labs have entered an agreement with UK-based CoM3D to develop digital 3D drug manufacturing and advanced drug delivery systems.

National Pharmacy Organizations Unite to Take a Stand Against Racial Injustice

Logo for the American Pharmacists Association.
June 26, 2020
The American Pharmacists Association (APhA) releases a message from national pharmacy associations to take a stand against racial injustice.

UT Pharmacy Students Excel at AMCP

Wavery and Zhang Thumbnail
May 5, 2020
UT College of Pharmacy students Waverly Yang and Shiyu (Serene) Zhang took top prizes at the Academy of Managed Care Pharmacy (AMCP) Foundation’s eLearning Days. The web-based poster hall took place April 20-24, 2020 and showcased 125 posters that were to be presented at the AMCP 2020 Annual Meeting.

Virtual Research Day 2020

Meek Research Day 2020
April 30, 2020
Despite social distancing, researchers were still able to participate in the 16th Annual Louis C. Littlefield Celebrating Pharmacy Research Excellence Day. Lectures, poster presentations, and abstracts were presented remotely to virtual attendees. See which abstracts took top awards during the online event.